All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation
During the 7th World Congress on Controversies in Multiple Myeloma (COMy), the Multiple Myeloma Hub spoke with María-Victoria Mateos, University Hospital of Salamanca, Salamanca, ES. We asked, Should cure be the goal for MM?
Multiple Myeloma Hub Satellite Symposium highlights: Should cure be the goal for MM?
Mateos firstly defines a cure for MM, focusing on survival differences with curable diseases. She then outlines a roadmap to achieve a cure, including novel agents, assessments to evaluate treatment efficacy, early detection and intervention, and risk stratification to guide treatment.
Sub-analysis of East Asian patients from the ALCYONE trial
the results of a sub-analysis of East Asian patients from the ALCYONE trial on the benefit of daratumumab in combination with bortezomib, melphalan, and prednisone
IMW 2019 | A.R.R.O.W.: Subgroup analysis by frailty score
Professor Mateos presented a subgroup analysis from the phase III A.R.R.O.W study at IMW 2019.
Subscribe to get the best content related to multiple myeloma delivered to your inbox